Trial Profile
Evaluation of the effectiveness and safety of Sofosbuvir plus Daclatasvir in the treatment for HCV or HIV/HCV with hemophilia
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 May 2016
Price :
$35
*
At a glance
- Drugs Daclatasvir (Primary) ; Sofosbuvir (Primary)
- Indications Haemophilia; Hepatitis C
- Focus Therapeutic Use
- 28 May 2016 New trial record